Cyanotech

News

2/25/13	UNPA Announces Three New Members
2/7/13	Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2013
2012
11/9/12	Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2013
9/13/12	Cyanotech Completes $5.5-Million Long-Term Loan to Support Growth Program
8/10/12	Cyanotech Reports Financial Results for the First Quarter of Fiscal 2013
7/16/12	Cyanotech Names Jim Lundeen VP/General Manager-Mainland for Nutrex Hawaii
6/21/12	Cyanotech Reports Financial Results for Fiscal Year 2012
5/14/12	Nutrex Hawaii Announces Scientific Advisory Board
2/9/12	Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2012
2011
11/14/11	Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2012
10/11/11	Cyanotech Announces 33% Expansion of Astaxanthin Production Capacity
8/17/11	Cyanotech Names Jole Deal as Chief Financial Officer
8/11/11	Cyanotech Reports Financial Results for the First Quarter of Fiscal 2012
6/23/11	Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2011
6/8/11	Cyanotech Names Thomas F. Chen as a Director
5/24/11	Senator Inouye Commends Cyanotech
4/21/11	Michael A. Davis Named Chairman of the Board of Directors of Cyanotech
2/16/11	UC Davis Research Study Indicates that Cyanotech’s Spirulina Pacifica® May Counter Anemia and Declining Immune Function in Persons Over Age 50
2/11/11	Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2011
1/28/11	Cyanotech Names Ralph Carlton as a Director
1/6/11	Cyanotech Says Its BioAstin® Natural Astaxanthin Obtains GRAS Status
2010
12/1/10	Natural Astaxanthin Praised by Dr. Joseph Mercola for Broad Health Benefits
11/10/10	Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2011
11/8/10	Cyanotech Names Brent Bailey as President, Chief Executive Officer and a Director
8/12/10	Cyanotech Reports Financial Results for the First Quarter of Fiscal 2011
7/2/10	Cyanotech Regains Full Compliance with Nasdaq
6/24/10	Cyanotech Reports Financial Results for Fiscal Year 2010
5/21/10	Cyanotech Receives Export Achievement Award From US Department of Commerce
3/12/10	Cyanotech Receives Temporary Non-Compliance Notice from Nasdaq Related to Its Number of Independent Directors
3/1/10	Cyanotech’s Board of Directors Names David I. Rosenthal as Interim President and CEO
2/11/10	Cyanotech Reports Financial Results for the Third Quarter of Fiscal 2010
2009
12/17/09	Cyanotech Launches New Hawaiian Spirulina Pacifica® Multi-Vitamins
12/10/09	Cyanotech Announces Discovery of Vitamin K2 in Hawaiian Spirulina Pacifica®
11/12/09	Cyanotech Reports Financial Results for the Second Quarter of Fiscal 2010
10/6/09	Cyanotech Lauded by State of Hawaii for 25 Years of Leadership
8/13/09	Cyanotech Reports Financial Results for the First Quarter of Fiscal 2010
6/24/09	Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal 2009
5/15/09	Cyanotech Implements Direct Registration System (DRS) for All Registered Shareholder Transactions
4/22/09	Cyanotech to Launch Hawaiian Spirulina Pacifica® Label Redesign Using FiberStone® Materials
4/21/09	Board of Directors Amends Cyanotech’s Bylaws
2/12/09	Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2009
1/30/09	Cyanotech’s Hawaiian Spirulina Pacifica® Achieves the Highest Nutritional Content Ever Recorded
2008
11/13/08	Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2009
10/31/08	Cyanotech Names Deanna Spooner as CFO
8/15/08	Cyanotech Reports Financial Results for the First Quarter of Fiscal 2009
7/16/08	Cyanotech Corporation Announces Selection of Grant Thornton LLP as Independent Registered Public Accountants
6/26/08	Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2008
5/19/08	Cyanotech Names Andrew Jacobson as President & CEO
3/26/08	Cyanotech Focuses Natural Astaxanthin Production on BioAstin® for Human Market, Discontinues Production of NatuRose® for Animal Feed Market in Strategic Move
2/14/08	Cyanotech Reports Financial Results for the Third Quarter of Fiscal 2008
1/31/08	Cyanotech Provides Marketing Update
2007
11/13/07	Cyanotech Announces Strategic Shift to Marketing-Oriented Business Model, Initiates Search for New President and CEO to Lead Effort
11/7/07	Cyanotech Reports Improved Financial Results for the Second Quarter of Fiscal 2008
10/15/07	Cyanotech Reports GMP Certification, Launches Two New Products
10/8/07	Cyanotech Receives Notice of Compliance from Nasdaq
9/21/07	Cyanotech Reports First Quarter Fiscal 2008 Financial Results
8/16/07	Cyanotech Files Form 10-K Financial Report for Fiscal 2007
6/5/07	Cyanotech Issues Statement on Product Integrity
4/4/07	Cyanotech Corp. Appoints Natural Products Industry Veteran Marc G. Ketchel to Serve as Director of Sales
3/16/07	Cyanotech Receives Notice of Compliance from Nasdaq
3/5/07	Cyanotech’s BioAstin® Natural Astaxanthin Is Officially Registered in the European Union
2/26/07	Cyanotech Files Form 10-Q Financial Reports for First Quarter and Second Quarter of Fiscal Year 2007; Delays Third Quarter Fiscal 2007 Form 10-Q Financial Report; Nasdaq Notice of Non-Compliance With Listing Requirement, and Cyanotech Request for Continued Nasdaq Listing
2/14/07	Cyanotech Files Fiscal Year 2006 Form 10-K/A Restating Its Financial Results; Seeks Delay of Third Quarter Fiscal 2007 Form 10-Q Financial Report
2006
12/20/06	Cyanotech Receives Extension from Nasdaq to File Its Late Reports and Restatements
11/14/06	Cyanotech Corporation Delays Filing
11/3/06	Cyanotech Corporation Announces Reverse Split of Its Par Value $0.005 Common Stockand Temporary 30-day Change in Its Symbol from CYAN to CYAND
10/16/06	Cyanotech Reports No Significant Damage from Earthquake
9/21/06	Cyanotech Board Approves 1-for-4 Reverse Stock Split and Other News
8/24/06	Cyanotech Receives Delisting Notice from NASDAQ Due to Late Filing of Form 10-Q
8/21/06	Cyanotech Continues Delay of First Quarter Fiscal 2007 Financial Results
8/16/06	Cyanotech 1Q07 Extension Filing
8/9/06	Cyanotech Delays First Quarter Fiscal 2007 Financial Results
5/31/06	Nasdaq Extends Cyanotech Listing Compliance Period to November 27, 2006
5/24/06	Cyanotech Reports 4QFY06 Results: Fiscal Year Sales Down 3%; 4Q Sales Up 27%
3/13/06	Earthrise and Cyanotech Claim Significant Differences between Organic and All-natural, American-made Spirulina
2/13/06	Astaxanthin softens sales blow for Cyanotech
2/8/06	Cyanotech Reports Third-Quarter Fiscal 2006 Financial Results
2/1/06	Hawaiian microalgae producer Cyanotech has become the latest company to tout its wares direct to consumers, with the initiation of an advertising campaign aimed at end users of BioAstin.
2/1/06	Cyanotech Corporation Announces FY 2006 Third Quarter Financial Results Webcast on February 8, 2006
1/31/06	Cyanotech Retains Media Relations for Consumer PR Campaign
1/11/06	Cyanotech counts on China for astaxanthin expansion
2005
12/13/05	Cyanotech Names William R. Maris as CFO
12/06/05	Cyanotech Receives Non-Compliance Notice from Nasdaq — Company has 180 days to comply
11/30/05	Cyanotech CEO Reports on Business Development Trip to Asia
11/03/05	Cyanotech Corporation Reports Second Quarter Fiscal 2006 Financial Results (Reports Sales of $2,517,000, Net Loss of $321,000)
10/28/05	Cyanotech Corporation Announces FY 2006 Second Quarter Financial Results Webcast on November 3, 2005
10/15/05	Cyanotech Corporation Announces Resignation of Jeffrey H. Sakamoto, Chief Financial Officer
08/31/05	Dutton Associates Announces Investment Opinion: Cyanotech Neutral Rating Based on Valuation Maintained by Dutton Associates
08/11/05	Cyanotech Corporation Reports First Quarter Fiscal 2006 Financial Results; Reports Net Income of $153,000 on Sales of $3,029,000
07/15/05	Dutton Associates Announces Investment Opinion: Cyanotech Neutral Rating Maintained By Dutton Associates
07/12/05	Cyanotech Appoints Russell Communications Group as Investor Relations and Marketing Communications Agency
06/08/05	Cyanotech Corporation Announces Results of Independent Laboratory Testing of Spirulina
05/16/05	Cyanotech Corporation Reports Fourth Quarter and Fiscal Year-End 2005 Financial Results; Company Reports Net Income of $486,000 for the Fiscal Year Ended March 31, 2005
2004
12/06/04	Dr. Gerald Cysewski, Chairman, President and CEO of Cyanotech Talks to The Wall Street Transcript
2003
11/11/03	United States-Grown Spirulina Completes FDA Generally Recognized As Safe(GRAS) Notification Process
2000
08/22/00	Cyanotech Receives FDA Approval for Its NatuRose® Salmon Feed Ingredient
01/18/00	Discover the brand-new fountain-of-youth vitamin—From "Woman World" Magazine
1999
08/12/99	Algae's Napa Valley—Feature in Los Angeles Times